Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

The 46-year-old single mum had hoped that she could deal with this on her own, but now her condition is only getting worse.

Diabetes patients on tirzepatide have lower risks for new or worsening diabetic retinopathy, eye complications, and the need for eye treatments than those relying on lifestyle interventions alone.

Selecting the right eye care provider involves evaluating multiple factors, including clinical expertise, infrastructure, technology, and long-term patient support. By prioritising safety and quality ...

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the same field among all institutes ...

In India, we are quick to visit a doctor for fever, stomach pain, or a bad cough. But when it comes to the eyes, most people ...

A new study published in the Journal of the American Medical Association showed that in the year after primary congenital glaucoma (PCG) surgery, rigid gas-permeable contact lenses ...

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2025 adjusted earnings per share (EPS) of $11.44, which ...

Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...